Personal information

Verified email addresses

Verified email domains

Molecular Imaging, MSOT, Vascular Disrupting Agents, Heme Target Agents
United States

Biography

Dr. Li Liu is an Associate Professor of Radiology and a member of the Simmons Comprehensive Cancer Center at UT Southwestern Medical Center (UTSW). She also serves as faculty for graduate programs in Biomedical Engineering. With extensive support from the National Cancer Institute (NCI), the Department of Defense (DOD) breast, prostate, and kidney cancer initiatives, as well as the Cancer Prevention and Research Institute of Texas (CPRIT), Dr. Liu and her dedicated research team have made significant contributions in the field. Their primary focus lies in the development of reporter genes and gene reporters for multimodality imaging in preclinical cellular and molecular studies, with a specific emphasis on small animal models of breast, prostate, brain, and lung cancers. Notably, recent advancements include dynamic bioluminescent imaging and multispectral optoacoustic tomography (MSOT) about vascular-disrupting agents and heme target agents in preclinical lung and kidney cancers. Dr. Liu's research stands at the forefront of preclinical innovations, paving the way for improved understanding and potential breakthroughs in cancer imaging and treatment.

Activities

Employment (1)

The University of Texas Southwestern Medical Center: Dallas, US

2021-09-01 to present | Associate Professor (Radiology)
Employment
Source: Self-asserted source
Li Liu

Education and qualifications (1)

Nankai University: Tianjin, CN

1999-09-01 to 2022-07-01 | Ph.D. (Microbiology)
Education
Source: Self-asserted source
Li Liu

Professional activities (2)

WMIS: Culver City, US

2006-01-02 to present
Membership
Source: Self-asserted source
Li Liu

AACR: Philadelphia, US

2005-05-31 to present
Membership
Source: Self-asserted source
Li Liu

Funding (1)

Image guided optimization of lung cancer treatment with novel heme-targeting agents

2024-12-01 to 2025-11-30 | Grant
American Cancer Society (Atlanta, US)
GRANT_NUMBER:

CAT-24-1377992-01-CAT

Source: check_circle
American Cancer Society - ProposalCentral

Works (4)

Innovative Imaging Techniques for Advancing Cancer Diagnosis and Treatment

Cancers
2024-07-22 | Journal article
Contributors: Tianyuan Wang; Yicheng Ni; Li Liu
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Demonstrating Tumor Vascular Disrupting Activity of the Small-Molecule Dihydronaphthalene Tubulin-Binding Agent OXi6196 as a Potential Therapeutic for Cancer Treatment

Cancers
2022-08 | Journal article | Author
Contributors: Li Liu; Regan Schuetze; Jeni L. Gerberich; Ramona Lopez; Samuel O. Odutola; Rajendra P. Tanpure; Amanda K. Charlton-Sevcik; Justin K. Tidmore; Emily A.-S. Taylor; Payal Kapur et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Imaging-Guided Evaluation of the Novel Small-Molecule Benzosuberene Tubulin-Binding Agent KGP265 as a Potential Therapeutic Agent for Cancer Treatment

Cancers
2021-09 | Journal article | Author
Contributors: Yihang Guo; Honghong Wang; Jeni L. Gerberich; Samuel O. Odutola; Amanda K. Charlton-Sevcik; Maoping Li; Rajendra P. Tanpure; Justin K. Tidmore; Mary Lynn Trawick; Kevin Pinney et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors

Molecules
2021-04 | Journal article | Author
Contributors: Li Liu; Devin O’Kelly; Regan Schuetze; Graham Carlson; Heling Zhou; Mary Lynn Trawick; Kevin Pinney; Ralph Mason
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Peer review (11 reviews for 5 publications/grants)

Review activity for Cancer letters. (3)
Review activity for Cancers. (5)
Review activity for Clinical & experimental metastasis. (1)
Review activity for International journal of molecular sciences. (1)
Review activity for Molecules. (1)